EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018

Xin Yun Teoh iD, Robinson Suganthy iD, Sook Yee Michelle Voo, Min Moon Tang, Malaysian Psoriasis Registry Working Group

Experimental Dermatology · 2023

DOI: 10.1111/exd.14770 ↗

At a glance

Übersichtsarbeit in Experimental Dermatology, 2023. Written by Xin Yun Teoh and 4 co-authors. Institution: Department of Dermatology, Hospital Queen Elizabeth, Ministry of Health Malaysia, Kota Kinabalu, Malaysia. Major MEDLINE topics: Psoriasis, Quality of Life. Cited 8 times so far (Crossref); 43 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Pustular psoriasis (PP) is an uncommon subtype of psoriasis with distinct genetic features and clinical phenotypes. Patients with PP tend to experience frequent flares and significant morbidity. This study aims to determine the clinical characteristics, co‐morbidities and treatment of PP patients in Malaysia. This was a cross‐sectional study of patients with PP notified to the Malaysian Psoriasis Registry (MPR) between January 2007 and December 2018. Of 21 735 psoriasis patients, 148 (0.7%) had pustular psoriasis. Of these, 93 (62.8%) were diagnosed with generalized pustular psoriasis (GPP) and 55 (37.2%) with localized PP (LPP). The mean age for pustular psoriasis onset was 31.71 ± 18.33 years with a male to female ratio of 1:2.1. Patients with PP were more likely to have dyslipidaemia (23.6% vs. 16.5%, p = 0.022), severe disease (Body surface area >10 and/or Dermatology Life Quality Index [DLQI] >10) (64.8% vs. 50%, p = 0.003) and require systemic therapy (51.4% vs. 13.9%, p < 0.001) compared to non‐PP patients. Patients with PP also suffered greater impairment to their quality of life (DLQI >10, 48.9% vs. 40.3%, p = 0.046), had more days off school/work (2.06 ± 6.09 vs. 0.5 ± 4.91, p = 0.004) and a higher mean number of hospitalizations (0.31 ± 0.95 vs. 0.05 ± 1.22, p = 0.001) in 6 months compared to non‐PP patients. Overall, 0.7% of psoriasis patients in the MPR had pustular psoriasis. Patients with PP had a higher rate of dyslipidaemia, severe disease, greater impairment of quality of life and systemic therapy usage compared to other psoriasis subtypes.

Subjects

MeSH terms (MEDLINE)

PsoriasisQuality of LifeFemaleHumansMaleCross-Sectional StudiesMalaysiaSeverity of Illness IndexAdultMiddle Aged

Author keywords

dermatology quality of lifegeneralized pustular psoriasisinterleukin-36localized pustular psoriasispsoriasis

Authors and institutions

  • Department of Dermatology, Hospital Queen Elizabeth, Ministry of Health Malaysia, Kota Kinabalu, Malaysia.
  • Department of Dermatology, Hospital Kuala Lumpur, Ministry of Health Malaysia, Kuala Lumpur, Malaysia.

ORCID profiles: Xin Yun Teoh, Robinson Suganthy

Cite

APA

Teoh, X. Y., Suganthy, R., Voo, S. Y. M., Tang, M. M., & Malaysian Psoriasis Registry Working Group (2023). Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018. Experimental Dermatology. https://doi.org/10.1111/exd.14770

Vancouver

Teoh XY, Suganthy R, Voo SYM, Tang MM, Malaysian Psoriasis Registry Working Group. Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018. Experimental Dermatology. 2023. doi:10.1111/exd.14770

BibTeX
@article{Teoh2023,
  author = {Teoh, Xin Yun and Suganthy, Robinson and Voo, Sook Yee Michelle and Tang, Min Moon and Malaysian Psoriasis Registry Working Group, Malaysian Psoriasis Registry Working Group},
  title = {Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018},
  journal = {Experimental Dermatology},
  year = {2023},
  doi = {10.1111/exd.14770}
}
Start for free →